Global leader in eye care selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, February 22, 2008 – clinivation, Inc. announced today that Alcon Laboratories, Inc., subsidiary of Alcon, Inc. (NYSE: ACL), has selected clinivation WorldView® Online Regulatory Intelligence web service.
“We are pleased that Alcon Laboratories has selected clinivation WorldView as their source for regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
“With comprehensive, authoritative, and up-to-date information, Alcon will be readily alerted of important updates to worldwide submission and approval processes,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Alcon, Inc.
Alcon, Inc. is the world’s leading eye care company, with sales of $5.6 billion in 2007. Alcon, which has been dedicated to the ophthalmic industry for more than 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon’s majority shareholder is Nestle, S.A., the world’s largest food company.
For more information, visit www.alcon.com.